Emerging evidences suggest that the AKT/mTOR pathway can activate a series of processes involved in tumor initiation and progression, including cell proliferation, differentiation, survival, chemoresistance and metastasis, and therefore may be a potential target for anticancer therapy16,31,32. The gene discussed is AKT1; the disease is neoplasm.